Comparison of two systemic steroid regimens for the treatment of COPD exacerbations


ÇEVİKER Y., SAYINER A.

PULMONARY PHARMACOLOGY & THERAPEUTICS, vol.27, no.2, pp.179-183, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.1016/j.pupt.2013.03.004
  • Title of Journal : PULMONARY PHARMACOLOGY & THERAPEUTICS
  • Page Numbers: pp.179-183

Abstract

Rationale: Systemic steroids shorten recovery time, improve lung function and hypoxemia in COPD exacerbations. Although several studies have shown that both parenteral and oral steroids are effective and GOLD guideline recommends use of oral steroids at a dose of 30-40 mg/day, very little data exists as to whether any route of admininstration (parenteral vs oral) or any dose is more effective and/or safer.